Vancomycin Enema denied for failing step therapy by Humana?

Humana's specific coverage criteria for vancomycin enema are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied Vancomycin Enema Under Step Therapy

Humana's step-therapy (also called "fail-first") protocol for colorectal conditions typically requires documented failure of, or contraindication to, one or more preferred therapies before a compounded or non-formulary preparation like vancomycin enema will be covered. If the prior-authorization request did not include adequate documentation of prior treatment steps, or if those steps were not completed in the sequence Humana requires, a step-therapy denial follows.

## Why This Denial Is Appealable

Step-therapy denials are overturned when the patient's chart clearly documents prior treatment attempts and their outcomes, or when the prescriber explains why required prior steps are clinically inappropriate for this specific patient. Most states have enacted step-therapy reform laws that require insurers to grant an exception when (a) the required drug has already been tried and failed, (b) the required drug is contraindicated or expected to cause an adverse reaction, or (c) the patient is stable on the prescribed therapy. Humana's step-therapy exception process is the procedural vehicle for these arguments.

## Federal Appeal Framework

• Step-therapy exception request: File this first, before or alongside the internal appeal, using Humana's published exception criteria. This is the fastest path to reversal.
• Internal appeal (ACA §2719 / ERISA §503): If the exception is denied, file a formal internal appeal. Humana must respond within 30 days (pre-service) or 60 days (post-service).
• Expedited appeal: Available within 72 hours if delay poses serious health risk.
• External IRO review: After final internal denial, request external review within approximately 4 months. IRO decisions bind Humana.

## Documentation to Gather

• Prior-treatment records: Dates, doses (as documented in the chart), and outcomes of each therapy tried in Humana's required sequence.
• Failure documentation: Chart notes, lab results, or prescriber statements showing why each prior step was inadequate — including intolerance, lack of efficacy, or clinical worsening.
• Contraindication evidence: If a required step drug is contraindicated for this patient, prescriber documentation explaining why.
• Clinical severity notes: Chart evidence that the patient's condition warrants prompt treatment and that delay to complete additional steps poses clinical risk.
• Prescriber medical-necessity letter: A focused letter stating which steps have been completed, why remaining steps are inappropriate, and why vancomycin enema is the clinically necessary next treatment.

## Criteria-Mapping Structure

Obtain Humana's step-therapy policy for the relevant condition. List each required treatment step. For each step, document the date trialed and outcome, or the clinical reason it was skipped. Present this as a numbered table in the appeal letter to make compliance unmistakable for the reviewer.